|
|
||||||||
Pathogenicity and Medical Microbiology |
Department of Microbiology and Immunology1 and Department of Medicine2, University of Western Ontario, London, Ontario, N6A 5C1, Canada
Department of Microbiology and Infection Control, London Health Sciences Centre, London, Ontario, N6A 4G5, Canada3
Author for correspondence: Miguel A. Valvano. Tel: +1 519 661 3996. Fax: +1 519 661 3499. e-mail: mvalvano{at}julian.uwo.ca
Strains of the Burkholderia cepacia complex have emerged as a serious threat to patients with cystic fibrosis due to their ability to infect the lung and cause, in some patients, a necrotizing pneumonia that is often lethal. It has recently been shown that several strains of the B. cepacia complex can escape intracellular killing by free-living amoebae following phagocytosis. In this work, the ability of two B. cepacia complex strains to resist killing by macrophages was explored. Using fluorescence microscopy, electron microscopy and a modified version of the gentamicin-protection assay, we demonstrate that B. cepacia CEP021 (genomovar VI), and Burkholderia vietnamiensis (previously B. cepacia genomovar V) CEP040 can survive in PU5- 1.8 murine macrophages for a period of at least 5 d without significant bacterial replication. Furthermore, bacterial entry into macrophages stimulated production of tumour necrosis factor and primed them to release toxic oxygen radicals following treatment with phorbol myristoyl acetate. These effects were probably caused by bacterial LPS, as they were blocked by polymyxin B. Infected macrophages primed with interferon gamma produced less nitric oxide than interferon-gamma- primed uninfected cells. We propose that the ability of B. cepacia to resist intracellular killing by phagocytic cells may play a role in the pathogenesis of cystic fibrosis lung infection. Our data are consistent with a model where repeated cycles of phagocytosis and cellular activation without bacterial killing may promote a deleterious inflammatory response causing tissue destruction and decay of lung function.
Keywords: Burkholderia cepacia, macrophage activation, intracellular survival, cystic fibrosis
Abbreviations: CF, cystic fibrosis; DCF, dichlorofluorescein; IFN-
, interferon gamma; PMA, phorbol myristoyl acetate; PMB, polymyxin B; TNF, tumour necrosis factor
This article has been cited by other articles:
![]() |
K. E. Keith, D. W. Hynes, J. E. Sholdice, and M. A. Valvano Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia Microbiology, April 1, 2009; 155(4): 1004 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. G. Holden, H. M. B. Seth-Smith, L. C. Crossman, M. Sebaihia, S. D. Bentley, A. M. Cerdeno-Tarraga, N. R. Thomson, N. Bason, M. A. Quail, S. Sharp, et al. The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients J. Bacteriol., January 1, 2009; 191(1): 261 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lamothe and M. A. Valvano Burkholderia cenocepacia-induced delay of acidification and phagolysosomal fusion in cystic fibrosis transmembrane conductance regulator (CFTR)-defective macrophages Microbiology, December 1, 2008; 154(12): 3825 - 3834. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U. Sajjan, L. A. Carmody, C. F. Gonzalez, and J. J. LiPuma A Type IV Secretion System Contributes to Intracellular Survival and Replication of Burkholderia cenocepacia Infect. Immun., December 1, 2008; 76(12): 5447 - 5455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Saldias, J. Lamothe, R. Wu, and M. A. Valvano Burkholderia cenocepacia Requires the RpoN Sigma Factor for Biofilm Formation and Intracellular Trafficking within Macrophages Infect. Immun., March 1, 2008; 76(3): 1059 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Flannagan and M. A. Valvano Burkholderia cenocepacia requires RpoE for growth under stress conditions and delay of phagolysosomal fusion in macrophages Microbiology, February 1, 2008; 154(2): 643 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Keith, L. Killip, P. He, G. R. Moran, and M. A. Valvano Burkholderia cenocepacia C5424 Produces a Pigment with Antioxidant Properties Using a Homogentisate Intermediate J. Bacteriol., December 15, 2007; 189(24): 9057 - 9065. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Keith and M. A. Valvano Characterization of SodC, a Periplasmic Superoxide Dismutase from Burkholderia cenocepacia Infect. Immun., May 1, 2007; 75(5): 2451 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Maloney and M. A. Valvano The mgtC Gene of Burkholderia cenocepacia Is Required for Growth under Magnesium Limitation Conditions and Intracellular Survival in Macrophages. Infect. Immun., October 1, 2006; 74(10): 5477 - 5486. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Whitby, T. M. VanWagoner, A. A. Taylor, T. W. Seale, D. J. Morton, J. J. LiPuma, and T. L. Stull Identification of an RTX determinant of Burkholderia cenocepacia J2315 by subtractive hybridization J. Med. Microbiol., January 1, 2006; 55(1): 11 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Mahenthiralingam and P Vandamme Taxonomy and pathogenesis of the Burkholderia cepacia complex Chronic Respiratory Disease, October 1, 2005; 2(4): 209 - 217. [Abstract] [PDF] |
||||
![]() |
M. D. Lefebre, R. S. Flannagan, and M. A. Valvano A minor catalase/peroxidase from Burkholderia cenocepacia is required for normal aconitase activity Microbiology, June 1, 2005; 151(6): 1975 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ortega, T. A. Hunt, S. Loutet, A. D. Vinion-Dubiel, A. Datta, B. Choudhury, J. B. Goldberg, R. Carlson, and M. A. Valvano Reconstitution of O-Specific Lipopolysaccharide Expression in Burkholderia cenocepacia Strain J2315, Which Is Associated with Transmissible Infections in Patients with Cystic Fibrosis J. Bacteriol., February 15, 2005; 187(4): 1324 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Huber, F. Feldmann, M. Kothe, P. Vandamme, J. Wopperer, K. Riedel, and L. Eberl Identification of a Novel Virulence Factor in Burkholderia cenocepacia H111 Required for Efficient Slow Killing of Caenorhabditis elegans Infect. Immun., December 1, 2004; 72(12): 7220 - 7230. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Hunt, C. Kooi, P. A. Sokol, and M. A. Valvano Identification of Burkholderia cenocepacia Genes Required for Bacterial Survival In Vivo Infect. Immun., July 1, 2004; 72(7): 4010 - 4022. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Levy, B. J. Chang, L. K. Abbott, J. Kuo, G. Harnett, and T. J. J. Inglis Invasion of Spores of the Arbuscular Mycorrhizal Fungus Gigaspora decipiens by Burkholderia spp. Appl. Envir. Microbiol., October 1, 2003; 69(10): 6250 - 6256. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Punj, R. Sharma, O. Zaborina, and A. M. Chakrabarty Energy-Generating Enzymes of Burkholderia cepacia and Their Interactions with Macrophages J. Bacteriol., May 15, 2003; 185(10): 3167 - 3178. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomich, A. Griffith, C. A. Herfst, J. L. Burns, and C. D. Mohr Attenuated Virulence of a Burkholderia cepacia Type III Secretion Mutant in a Murine Model of Infection Infect. Immun., March 1, 2003; 71(3): 1405 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gronow, C. Noah, A. Blumenthal, B. Lindner, and H. Brade Construction of a Deep-rough Mutant of Burkholderia cepacia ATCC 25416 and Characterization of Its Chemical and Biological Properties J. Biol. Chem., January 10, 2003; 278(3): 1647 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Segal, L. Ding, and S. M. Holland Phagocyte NADPH Oxidase, but Not Inducible Nitric Oxide Synthase, Is Essential for Early Control of Burkholderia cepacia and Chromobacterium violaceum Infection in Mice Infect. Immun., January 1, 2003; 71(1): 205 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Lefebre and M. A. Valvano Construction and Evaluation of Plasmid Vectors Optimized for Constitutive and Regulated Gene Expression in Burkholderia cepacia Complex Isolates Appl. Envir. Microbiol., December 1, 2002; 68(12): 5956 - 5964. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schwab, M. Leigh, C. Ribeiro, J. Yankaskas, K. Burns, P. Gilligan, P. Sokol, and R. Boucher Patterns of Epithelial Cell Invasion by Different Species of the Burkholderia cepacia Complex in Well-Differentiated Human Airway Epithelia Infect. Immun., August 1, 2002; 70(8): 4547 - 4555. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Chu, D. J. Davidson, T. K. Halsey, J. W. Chung, and D. P. Speert Differential Persistence among Genomovars of the Burkholderia cepacia Complex in a Murine Model of Pulmonary Infection Infect. Immun., May 1, 2002; 70(5): 2715 - 2720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomich, C. A. Herfst, J. W. Golden, and C. D. Mohr Role of Flagella in Host Cell Invasion by Burkholderia cepacia Infect. Immun., April 1, 2002; 70(4): 1799 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Cieri, N. Mayer-Hamblett, A. Griffith, and J. L. Burns Correlation between an In Vitro Invasion Assay and a Murine Model of Burkholderia cepacia Lung Infection Infect. Immun., March 1, 2002; 70(3): 1081 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
C A. Hart and C. Winstanley Persistent and aggressive bacteria in the lungs of cystic fibrosis children Br. Med. Bull., March 1, 2002; 61(1): 81 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Gobert, D. J. McGee, M. Akhtar, G. L. Mendz, J. C. Newton, Y. Cheng, H. L. T. Mobley, and K. T. Wilson Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival PNAS, November 20, 2001; 98(24): 13844 - 13849. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Chiu, S. Wong, R. E. W. Hancock, and D. P. Speert Adherence of Burkholderia cepacia to respiratory tract epithelial cells and inhibition with dextrans Microbiology, October 1, 2001; 147(10): 2651 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sajjan, G. Thanassoulis, V. Cherapanov, A. Lu, C. Sjolin, B. Steer, Y. J. Wu, O. D. Rotstein, G. Kent, C. McKerlie, et al. Enhanced Susceptibility to Pulmonary Infection with Burkholderia cepacia in Cftr{-}/{-} Mice Infect. Immun., August 1, 2001; 69(8): 5138 - 5150. [Abstract] [Full Text] [PDF] |
||||
![]() |
C-H. CHIU, A. OSTRY, and D.P. SPEERT Invasion of murine respiratory epithelial cells in vivo by Burkholderia cepacia J. Med. Microbiol., July 1, 2001; 50(7): 594 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. SAJJAN, M. COREY, A. HUMAR, E. TULLIS, E. CUTZ, C. ACKERLEY, and J. FORSTNER Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients J. Med. Microbiol., June 1, 2001; 50(6): 535 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Lefebre and M. A. Valvano In vitro resistance of Burkholderia cepacia complex isolates to reactive oxygen species in relation to catalase and superoxide dismutase production Microbiology, January 1, 2001; 147(1): 97 - 109. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |